Eur Heart J 2009;30:3015 26. 288. Oliva F, Latini R, Politi A, et al. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J 1999;138:247 53. 289. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circu- latory support with a continuous- ow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312 21. 290. Alba AC, Rao V, Ross HJ, et al. Impact of xed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients. J Heart Lung Transplant 2010;29:1253 8. 291. Elhenawy AM, Algarni KD, Rodger M, et al. Mechanical circulatory support as a bridge to transplant candidacy. J Card Surg 2011;26:542 7. 292. Nair PK, Kormos RL, Teuteberg JJ, et al. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant 2010;29:201 8. 293. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous- ow device in patients awaiting heart transplantation. N Engl J Med 2007; 357:885 96. 294. Lahpor J, Khaghani A, Hetzer R, et al. European results with a contin- uous- ow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg 2010;37:357 61. 295. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous ow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890 8. 296. Grady KL, Meyer PM, Dressler D, et al. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg 2004;77:1321 7. JACC Vol. 62, No. 16, 2013 Yancy et al. 